Change 5-day change 1-year change 3-year change Capi.($)
+2.42%-.--% - - 0
+0.13%+4.41%+48.19%+163.20% 1,067B
+0.97%+6.88%+60.00%+53.12% 635B
-0.94%+1.39%+36.28%+72.60% 458B
+1.41%+7.75%+38.93%+32.88% 347B
+1.28%+2.82%+38.42%+43.21% 295B
+1.72%+2.33%+19.31%+20.79% 262B
+1.84%-1.03%-27.78%-38.45% 216B
+0.06%+3.32%+24.88%+59.40% 203B
+0.94%-2.02%+15.47%+70.59% 161B
Average +1.32%+1.33%+28.19%+53.04% 404.83B
Weighted average by Cap. +0.87%+1.95%+37.75%+78.43%
Logo Shire
Shire specializes in developing, producing, and marketing pharmaceutical products for the treatment of nervous system dysfunctions (hyperactivity, epilepsy, Alzheimer's disease, etc.), cancer, gastro-intestinal illnesses, and infectious diseases. Net sales break down by source of income as follows: - sales of products (95.3%); - other (4.7%): primarily franchise royalties. Net sales break down geographically as follows: the United States (63.6%), Ireland (0.4%) and other (36%).
Employees
-